Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 2
2008 2
2009 2
2010 4
2011 2
2012 3
2013 4
2014 3
2015 2
2016 2
2017 1
2018 1
2019 2
2020 3
2021 4
2022 3
2023 3
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Lung Cancer in Serbia.
Cavic M, Kovacevic T, Zaric B, Stojiljkovic D, Korda NJ, Rancic M, Jankovic R, Radosavljevic D, Stojanovic G, Spasic J. Cavic M, et al. Among authors: rancic m. J Thorac Oncol. 2022 Jul;17(7):867-872. doi: 10.1016/j.jtho.2022.04.010. J Thorac Oncol. 2022. PMID: 35750454 Free article. No abstract available.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators. Thatcher N, et al. Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1. Lancet Oncol. 2015. PMID: 26045340 Free article. Clinical Trial.
Microwave Fluorescence Detection of Spin Echoes.
Billaud E, Balembois L, Le Dantec M, Rančić M, Albertinale E, Bertaina S, Chanelière T, Goldner P, Estève D, Vion D, Bertet P, Flurin E. Billaud E, et al. Among authors: rancic m. Phys Rev Lett. 2023 Sep 8;131(10):100804. doi: 10.1103/PhysRevLett.131.100804. Phys Rev Lett. 2023. PMID: 37739386
Single-electron spin resonance detection by microwave photon counting.
Wang Z, Balembois L, Rančić M, Billaud E, Le Dantec M, Ferrier A, Goldner P, Bertaina S, Chanelière T, Esteve D, Vion D, Bertet P, Flurin E. Wang Z, et al. Among authors: rancic m. Nature. 2023 Jul;619(7969):276-281. doi: 10.1038/s41586-023-06097-2. Epub 2023 Jul 12. Nature. 2023. PMID: 37438594
Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization.
Markovic-Denic L, Popadic D, Jovanovic T, Bonaci-Nikolic B, Samardzic J, Tomic Spiric V, Rancic M, Sankar Datta S, Mosina L, Jancic J, Vukomanovic G, Jovanovic V, Vukomanovic V, Antic D, Veljkovic M, Saponjic V, Jacques-Carroll L. Markovic-Denic L, et al. Among authors: rancic m. Front Public Health. 2022 Nov 17;10:1056670. doi: 10.3389/fpubh.2022.1056670. eCollection 2022. Front Public Health. 2022. PMID: 36466511 Free PMC article.
49 results